Screening Technologies for Target Identification in Pancreatic Cancer

Screening Technologies for Target Identification in Pancreatic Cancer

Pancreatic cancer exhibits an extraordinarily high level of resistance to almost any kind of systemic therapy evaluated in clinical trials so far. Therefore, the identification of novel therapeutic targets is urgently required. High-throughput screens have emerged as an important tool to identify pu...

Full description

Bibliographic Details
Main Authors: Thomas Gress, Malte Buchholz, Patrick Michl, Stefanie Ripka
Format: Article
Language:English
Published: MDPI AG 2010-12-01
Series:Cancers
Subjects:
pancreatic cancer
high-throughput screen
microarray
RNA interference
loss-of-function screen
Online Access:http://www.mdpi.com/2072-6694/3/1/79/

Internet

http://www.mdpi.com/2072-6694/3/1/79/

Similar Items